Holen Sie sich die Stockscreener-App
1.18
0.84%
-0.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$1.19
Offen:
$1.19
24-Stunden-Volumen:
12,512
Relative Volume:
0.13
Marktkapitalisierung:
$25.58M
Einnahmen:
$179.02M
Nettoeinkommen (Verlust:
$-57.29M
KGV:
-0.4293
EPS:
-2.7487
Netto-Cashflow:
$-33.01M
1W Leistung:
+0.00%
1M Leistung:
-15.71%
6M Leistung:
-47.79%
1J Leistung:
-54.44%
1-Tages-Spanne:
$1.1672
$1.20
1-Wochen-Bereich:
$1.15
$1.2651
52-Wochen-Spanne:
$1.15
$4.10
Petmed Express Inc Stock (PETS) Company Profile
Firmenname
Petmed Express Inc
Sektor
Branche
Telefon
(561) 426-4444
Adresse
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, SCNX, POM, RDGT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.18 | 25.58M | 179.02M | -57.29M | -33.01M | -2.7487 |
HITI
High Tide Inc
|
2.66 | 237.12M | 486.49M | -33.29M | 10.86M | -0.3627 |
SCNX
Scienture Holdings Inc
|
3.49 | 5.73M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
1.99 | 5.53M | 0 | 0 | 0 | 0.00 |
RDGT
Ridgetech Inc
|
0.8305 | 3.01M | 111.62M | 762.70K | 16.36M | -85.73 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-25 | Eingeleitet | Lake Street | Buy |
| 2022-01-20 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Underweight |
| 2021-10-01 | Eingeleitet | Jefferies | Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-06-03 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-03-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-01-27 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-19 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-03-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-02-24 | Herabstufung | Sidoti | Buy → Neutral |
| 2019-08-16 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-06-15 | Eingeleitet | CL King | Neutral |
| 2017-08-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-07-24 | Hochstufung | Northcoast | Neutral → Buy |
| 2016-05-09 | Hochstufung | Craig Hallum | Sell → Hold |
| 2016-02-04 | Eingeleitet | Credit Suisse | Underperform |
| 2010-07-19 | Herabstufung | CL King | Strong Buy → Accumulate |
| 2010-07-19 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-05-25 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-05-06 | Bestätigt | Wedbush | Neutral |
| 2010-03-23 | Herabstufung | Janney Mntgmy Scott | Buy → Neutral |
| 2010-03-18 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2010-02-16 | Bestätigt | CL King | Strong Buy |
| 2009-07-21 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2009-01-07 | Eingeleitet | CL King | Strong Buy |
Alle ansehen
Petmed Express Inc Aktie (PETS) Neueste Nachrichten
Form 4 PetMed Express Inc: Jeffrey Allen Willard (Director, CEO and President) For: 28 September - Investing.com South Africa
PetMed Express, Inc. Estimates – NASDAQ:PETS - TradingView
PetMed Express stock gains 4.35 percent on Nasdaq. Morgan Stanley holds USD 1.40 target - AD HOC NEWS
PetMed Express, Inc. Actuals & Estimates (HAM:PQM) - TradingView
PetMed Express (Nasdaq:PETS)Stock Analysis - Simply Wall Street
PetMed Express appointed Tamar Elkeles and PetMed Express stock stayed unchanged - AD HOC NEWS
Cash flow from operating activities of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Willard Granted 500,000 Shares in Equity Awards - Kalkine Media
Current ratio of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Allen Willard Files Initial SEC Ownership Disclosure - Kalkine Media
A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - stocktitan.net
Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - stocktitan.net
PetMed Express Files to Register 1.8 Million Additional Shares Under Updated 2024 Incentive Plan - Kalkine Media
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView
PETS Maintains Rating by Morgan Stanley -- Price Target Lowered to $1.40 - gurufocus.com
PetMed Express Is Maintained at Underweight by Morgan Stanley - Moomoo
Form 8K PetMed Express Inc For: 22 September By Investing.com - Investing.com Canada
PetMed Express appoints Tamar Elkeles to board of directors By Investing.com - Investing.com Nigeria
PetMed Express appoints Tamar Elkeles to board of directors - Investing.com
PetMeds Appoints Tamar Elkeles to Board Amid Leadership Transition - citybiz
Qualcomm’s former talent chief joins PetMeds’ board - Stock Titan
PetMed Express Names Jeff Willard CEO Amid Transformation - The Globe and Mail
PetMeds Names Jeff Willard CEO as Justin Mennen Becomes Board Chair - citybiz
PetMeds will get a new CEO Sept. 28 as its board chair retires - Stock Titan
PetMeds Appoints Andrew Parry as Chief Technology Officer - Yahoo Finance
PetMed Express Names Andrew Parry Chief Technology Officer - Yahoo Finance
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeVolume Dry Up - vinanet.vn
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeEntry Point Alerts - dars.gov.et
PetMed Express Inc. (PETS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet - AlphaStreet
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - AOL.com
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - The Globe and Mail
Petwealth and Kennel Connection Accelerate Partnership Following Strong Industry Response at SuperZoo 2026 - AOL.com
PetMed (PETS) Financial Update: EPS Falls Short of Its Estimate at the Close; After Earnings: The Stock Loses 1.67% in Latest TradingShare Repurchase Impact - vinanet.vn
150-year-old Cheltenham pharmacy rescued from administration - AOL.co.uk
Petmed Express Inc (PETS) Stock News Today - TradingKey
Full Transcript: PetMed Express Q1 2027 Earnings Call - Sahm
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - Yahoo Finance
PetMed Express Q1 2027 Earnings Call Transcript - MarketBeat
PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million - TradingKey
PetMeds® Announces First Quarter Financial Results - The Manila Times
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - TradingView
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express earnings missed by $0.40, revenue fell short of estimates - Investing.com Canada
PetMed Express, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Is PetMed Express Inc (PETS) a Value Opportunity After Q1 Earnin - GuruFocus
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com Nigeria
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com South Africa
Finanzdaten der Petmed Express Inc-Aktie (PETS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.65%
2.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):